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T he purpose of this study was to determin e whether ke-
ratinocytes in certain disease states such as cutaneous T-
cell lymphoma and lichen pl anus, express HLA-DR anti-
gens (corresponding to the m urine I-E antigens) only or 
whether they are also ca pable of expressing HLA-DQ an-
tigens (analogues of the murine I-A anti gens). 
C ryos tat sections from 11 biopsies from cutaneous T-
cell lymphoma and from 11 lichen planus biopsy specimens 
were sub mitted to indirect immunoflu o rescence and a 4-
step immunoperoxidase method. This consists of applying 
monoclonal antibodies recognizing HLA-DR and HLA-
D Q molecules and the intracy toplasmic inva riant chain of 
D u rin g thc las t fcw years it has been am ply docu-mentcd th at ke ratin ocytes (K C) w hi ch, un der nor-m al ci rc~m s tan ces bca r class I alloa nti gens onl y [1], are ca pable o f express in g and even synthesizin g cl ass II alloantigens in ccrtain diseases (HLA-DR) (for 
rcvicw, sce [2]) . T he HLA-D regio n, however, encodes also for 
o thcr cl ass II m oleculcs, HLA-D Q and HLA-DP, w hi ch pl ay an 
additi o nal role in the inductio n o f thc immunc response [3]. Rc-
cen t rcports suggestcd that subpo pulati ons o f human hem ato-
poieti c stcm cell s [4] and peripheral blood m onocytcs (PBM) exist 
that exprcss either HLA-DR and HLA-D Q antigens o r HLA-DR 
antigens onl y [5], and thu s perform diffcrcnt fun ctions in tri g-
gering autologous or allogeneic T-cell pro li fe ration [5J. We wanted 
to dcterm ine w heth er K C under pathologic conditi ons express 
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Abbreviations : 
AMLR: autologous mixed leukocyte reaction 
CTCL: cutaneous T-ce ll lymphoma 
CTL: cytotox ic T lymphocytes 
DAB: dia minobenzidine 
FITC: fl uorescein isothiocyanate 
HRPO : horseradish peroxidase 
IFN-y: interfe ron ga mma 
Il F: indirect immunofluorescence 
IP: immunoperoxidase 
K C: keratinocyte(s) 
LC: Langerhans ce lls 
LP: lichen pl anus 
mAb(s) : monoclonal antibody(ies) 
PB M: peripheral blood monocytes 
PBS: phosphate-buffered saline 
RT: room temperature 
the class II molecules. In 8 of the 11 cutaneous T-cell lym-
phoma specimens and in 3 of the 11 lichen planus biopsies 
concomitant expression of HLA-DR and HLA-DQ mol-
ecules by keratinocytes was detectable with the immuno-
peroxidase method . However, with the indirect immu-
noflu orescence technique HLA-DQ anti gens on 
keratinocytes could not be detected. The simultaneous 
expression of surface-bound HLA-DR antigens and intra-
cy toplasmic y-chains w as demonstrable in all cases inves-
tigated and with both the immunohistologic methods ap-
plied. J Inv est D en'l1ato/ 89:64-68, 1987 
HLA-DR onl y, o r HLA-DR and DQ antigens simultaneously. 
To elucidate this qu estion we employcd 2 immuno histochemi ca l 
tcchniques : indirect immuno flu o rescence (IIF) and a m o rc sen-
sitivc 4-step immunoperox idase tcchniqu e (IP). W e applied 3 
m o no clonal antibodics (mAbs) directed again st cl ass II m o ieties 
(anti-HLA-DR [6], anti-Leu 10 [7], and VI C -Y1 [8)). The m ateri al 
used consisted o f cryos tat sectio ns fro m bio psies o f patients with 
diseases kn own to revea l KC - associated class II alloantigcns [cu-
taneous T-cell lymph o m a (C T C L) and lichen planu s (LP)]. 
MATERIALS AND M ETHODS 
Biopsies Full thickncss bio psies were o bta in ~d under local anes-
thesia in 11 patients w ith clinicall y typical LP and 11 patients w ith 
CTCL after info rmed consent had bcen o btained . Biopsy speci-
mens were divided into 2 pieces and processed for routine histo-
patho logy with fi xa tion in 8% fo rm aldehyde and fo r immuno-
histo logy. 
Immunohistologic Procedures Specimens w ere snap frozen 
in isopentane, cooled in liquid nitrogen , and sto red at -70°C 
until further use . Four-micron cryos tat sectio ns w ere mounted 
on glass slides, air dried , fi xed w ith aceton e fo r 10 min at room 
temperature (RT), and sto red at - 20°C. Fo r lIF , sections were 
thawed , air dried , and then incubated with the appro priately di-
luted 1 st step reagen ts (anti- HLA-DR, anti-Leul 0, VI C - Yl ) fo r 
30 min at RT in a m o ist chamber. Sectio ns w ere then rin sed in 
phosphatc-buffered saline (PBS) fo r 10 min and subsequcntl y 
overl ayered with the 2nd step reagent, antimollse IgG (Tago, 
Burlin ga m e, Ca lifo rni a) whi ch w as labeled w ith flu o rescein iso-
thiocya nate (FITC). A fter the sccond incubation (30 min, m oist 
chamber, RT) secti ons w ere w ashed again, air dried , and m o unted 
in gly cerin-PBS. 
A 4-stcp IP procedure was perfo rmcd as follo w s: beforc in-
cubation , cryos tat sectio ns w ere aga in subj ected to ace to ne fi x-
ation (10 min , RT) fo ll o w ed by a 10 min immersion in chl o ro-
fo rm . Air dried sections wcrc then incubated for 45 min w ith 100 
JLI of thc appropriately diluted mAb. The antibod y chain was 
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Table I. M onoclonal Antibodies U sed 
Monoclonal Antigenic 
Antibody Reference Ig C lass Wo rking Dilution Determ inant 
IgG 2" 1:40 (II F) HLA-DR 
1:100 (IP) (XI f3 chain 
complcx 
IgG I 1:10,50, 100 (II F) HLA-DQ 
1:100 (IP) molecules 
II F = indirect iml11l1ll o Ali OrCsccIl Cl' 
IP = imllllll1 o pc rox idasc 
IgG I 
Figure 1. IIF technique. Demonstration of sur face-bo und HLA-DR mol-
ecules on KC (A), of in variant chain within the cytoplasm of KC (B), 
but nonreactivity of HLA-DQ molecules o n o r in KC (C) . 
1:10 (I IF) Invariant 
1:600 (IP) (y) chain (s) 
Figure 2, IP techniquc. HLA-DR mo lecules are vis ible on the surface 
(A) and within the peripheral cy toplasm (A), respectively, ofKC w hereas 
the invariant chain (s) are seen with in the cytoplasm of the very sa me KC 
(B) . HLA-DQ moieties are to be observed on the surface (C) and wi thin 
the peripheral cy toplasm (C) at least of foc i of KC. 
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prolonged by 3 consecutive 30-min incubation steps at RT usin g 
horseradish peroxidase (HRPO) rabbit anti mouse Ig serum, HRPO 
swine anti rabbit Ig serum , and finally, HRPO rabbit antiswine 
Ig serum (a ll Dakopatts, Copenhagen, Denmark , working di-
lu tion 1 :20 in 1:2 Tris-NaCI(pH 7.4): heat inactivated human AB 
serum) with severa l T ris-NaCI (pH 7.4) was hes after each in-
cubation step. Sections were then subj ected to the diaminoben·· 
zidine (DAB) react ion (6 mg DAB in 10 ml Tris-HCl, pH 7.6). 
After nuclear counterstaining with hematoxy lin , sections were 
mounted in Kaiser's glycerol gelatin . 
Monoclonal Antibodies Monoclonal antibod ies used are li sted 
in Table I. 
RESULTS 
Lichen Planus In all 11 biopsy specimens tested with the IIF 
and IP methods, KC displayed HLA-DR 0i/{3 chains on their 
surface (Fig l A) and w ithin their periph era l cytoplas m, respec-
tive ly, whereas invariant chains were observed on ly within the 
cytop lasm of the KC (Fig 1B and Table 1I) . With I1F no DQ 
antigen expression by KC was detectable (Fig 1 C), neither on the 
cell surface nor with in the cytoplasm, whereas DQ antigens were 
easily detectab le on Langerhans cells (LC). With IP , however, 
DQ molecules were visua lized focally on the surface of KC (Fig 
2C) in add ition to HLA-DR and y-chain expression (Fig 2A, 2B) 
in the biopsy from patient 4. These antigens were observed within 
both the KG cytoplasm and on KC surfaces in the biopsies from 
patients 5 and 8 (Tab l~ II). 
Cutaneous T-Cell Lymphoma Whereas with the II F proce-
dure, HLA-DR 0i/{3 chains were detected on the surface and within 
the periphera l cytoplasm of KC and, simultaneously, y chains 
were observed within the cytoplasm of the KC in all 11 biopsy 
specimens (Table III), DQ molecules were not detected on or in 
KC, though they were clearly visualized on LC. Again, in con trast 
to the lIF technique, DQ antigens as detected by anti-Leu1 0 were 
seen within the peripheral cytoplasm and on the surface of the 
KC in 8 of 11 biopsies (Table III ). T here was no co rrelation 
between the detectability and the density of KC-bound HLA-
DQ moieties and the stage of CTCL. 
In all LP and CTCL biopsies HLA-DQ molecules on KC were 
on ly detectable when HLA-DR antigens were present in and on 
KC, but never without DR expression . 
D ISC U SSIO N 
C lass II aUoantigens normally exhibit a limited distribution in 
vivo [10]. But it has also been amply documented on murine and 
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human cell s that under the influence of the Iymphokine interferon 
gamma (IFN-y) the expression of HLA-DR antigens is enhanced 
or cven induced in cells which usually do not carry these moieties 
[11-14]. This includes cultured human KC [15 ,16). Da ta on the 
presence of HLA-DQ antigens on such cells have remained in-
conclusive since HLA-DQ antigens were either not detectable 
[14,15) or were present onl y on a sma ll number of cells [1 6J. 
In the present stud y we demonstrated that whereas IIF tech-
niqucs fail to detect HLA-DQ on KC the IP techniques allow the 
visuali zation of these very class II all oanti gens on KC in a con-
siderable number of CTCL and a few LP patients. This can be 
attributed to the fact that the 2-step IIF is rather insensitive com-
pared with the 4-step IP. Vice versa one may argue that by using 
a 4-step immunohistochemical procedure the risk of being too 
sensiti ve thereby showing "artifacts" is higher. T his latter pos-
sibili ty seems unlikely since it has been shown that HLA-DQ 
antigens are inducible too, though usuall y to a lesser extent (1 6). 
In addition, it has been demonstrated that the density of HLA-
DQ molecules on cell surfaces is usually approximately 5-fold 
lower than that of HLA-DR molecules [17] and this may be one 
reason for nonreactivity with lIF rather than lower an tibody af-
finity. 
T he apparent differences in the detectability ofHLA-DQ versus 
HLA-DR in CTCL and LP lesions deserve a number of consid-
erations though they cannot be fully explained· at present. By 
measuring the RNA transcripts of the HLA-DR, HLA-DQ, and 
HLA-DP heavy and light chains including the non-major his-
tocompatibility complex encoded invariant chain, Collins et al 
[18] demonstrated, at least for human endothelial cells and dermal 
fibroblasts, that whereas all class II molecules are induced si-
multaneously by IFN-y after 4-6 days in vitro HLA-DQ antigens 
are induced to a lesser extent. Th is result may be partly ascri bed 
to the cell types llsed, for other studies using human pre-B cell 
lines have indicated that HLA-DR is expressed before HLA-DQ 
[1 9] . In contrast, a study using a melanoma cell line, a B lym-
phoblastoid cell line, and PBM, has demonstrated that upon ex-
posure to IFN-y these cell types expressed HLA-DQ antigens 
ea rlier and to a greater extent than HLA-DR antigens [20]. Con-
trols with mAbs against non polymorphic determinants were not 
performed in this study. Thus, it is not clear whether the reported 
resuits are to be ascribed to the em.ployed antisera which were 
directed against the polymorphic and not the monomorphic de-
terminants recognized by the mAbs used in other studies [20], as 
was the case in our study. 
We cannot completely exclude the possibility that the deter-
minants on KC detected by the anti-Leu-1 0 mAb resulted from 
Table II. C lass II Antigens on Keratinocytes in Lichen Planus 
A nti-HLA-DR Type of Li chen Pl anus Anti- Leu 10 VIC-Yl 
Patient Genera li zed Localized II F IP 
1 + +++ +++ (C + S) 
2 + ++ ++ (S) 
3 + ++ ++ (C + S) 
4 + ++ + + (C + S) 
5 NE NE +++ +++ (S) 
6 + ++ ++ (S) 
7 + ++ +'+ (S) 
8 NE NE +++ +++ (C + S) 
9 + + + (S) 
10 + + + (S) 
11 + + + (S) 
II F = indirect immulloAuorcsccncc 
IP = il11l11unopcrox idasc 
C = cytoplas m 
S = surface 
NE = not eva luab le 
+ + + = intense band-like dark brown stain ing of keratinocyte sutface and peripheral cytop lasm 
+ + = intense stainin g predominantly of keratinocyte surface 
IIF IP 
+ (S) 
+ (C + S) 
+ (C + S) 
+ = di stin ct surr., ee staining of keratinocytes, either of g roups of keratinocy tes and/or basal kerat inocytes mainly. 
IIF IP 
+++ +++ 
+ + 
+ + 
+ + 
+ + 
+ + 
+ +/+ + 
+ + 
+ + 
+ + 
+ + 
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Table III. C lass II Antigens on Keratinocytes in C utaneous T -Cell Lym pho ma 
Patient Stage* 
IA 
2 II 
3 IA 
4 II A 
5 IA 
6 IB 
7 IA 
8 IVB 
9 li B 
10 IB 
11 III 
'Stag ing acco rding to 191. 
IIF = indirect immull o Auo rcsccncc 
IP = illll11uflopcrox idasc 
C = cytop lasm 
S = sur r.lee 
ND = not do ne 
anti-HLA-OR 
llF IP 
+ + 
+++ +++ 
++ ++ (C + S) 
+++ +++ 
+ + 
+++ +++ (C + S) 
-/+ - / + 
++ +++ 
++ +++ 
++ +++ 
+ ++ 
anti-Leu 10 V IC -VI 
IIF IP II F IP 
-/ + - / + 
++ (C + S) + ++ +++ 
N O + + + 
+ (C + S) ++ ++ 
++ ++ 
+++ (C + S) +++ + ++ 
ND - / + - / + 
+++ (C + S) ++ +++ 
++ ++ +++ 
++ + ++ 
+ + +++ 
+ + + = intense band-like dark brown sta ining of keratinocy te surface and pe ripheral cytop lasm 
+ + = intellse s tainin g prcdo mill and y of kc rat in ocyrc surfa ce 
+ = distinct surf.1 ce staining of keratinocytes. either of groups of kerati nocytes and/or basa l ke ratinocy tes main ly. 
cross-reacti vities wi th HLA-DR antigens, because no HLA-phe-
notyping was perform ed in the patients tested . We do, however, 
consider this possibility unlikely. 
Interestingly, studi es by C laesson-Welsh et al [21) who used a 
rat mAb recognizilig the COOH-terminal portion of the y-chain 
did not sho w a co rrelation between cell-surface expression of 
HLA-DR antigcn and the simultanco us presence of cytoplas mic 
y-chains. This may be partly due to the possibility that this mAb 
may recogn ize anothcr determinant which may bc associated with 
HLA-DQ rather than HLA-DR determinants. Even more sur-
prising is the fact that the authors reported on a cell surface ex pres-
sion of the 21:9 reactive y-chain molecule, because this COO H 
terminal of the y-chain is supposed to be found within the pe-
riphera l cytoplas m, or, at least, on thc inner sidc of the cellmem-
brane owing to an inverted arrangement of the y-chain [22). 
In our studies far more biopsies from CTCL than LP paticnts 
revea led the simultaneous ex pression of HLA-DR and HLA-DQ 
antigens. In CTCL anti-Leu3a + T cells and in LP, a mi xed in-
filtrate composed of anti-Leu3a + and anti-Lcu2a + T cells- of 
which a certain proportion additionall y exprcsses HLA-DR an-
ti gens-infiltratc the subepiderm al tissue or evcn the cpidermis 
proper. One may therefore assume that suffi cient amounts of 
IFN-y are produced by these cell populations [23) to inducc HLA-
DR/ DQ ex pression of KC but this is not enough to explain the 
higher HLA-DR/ DQ reactivity of KC in CTCL. 
Whether class U antigen biosynthesis enables KC to playa rolc 
in the induction of the immune response and w hethcr the differ-
ential expression of different class II antigens has any influence 
on a putative immunologic role of KC has been and still remains 
the subj ect of various studies. Whi le it has been shown that human 
thyroid cells express ing HLA-DR antigens are capable of pre-
senting at leas t peptide antigens to T-cell clones and thus inducing 
proliferation [24], at present no such data exist for KC. Prelim-
inary reports suggest that cells which normall y do not express 
class II alloantigens but do so under the influence of IFN-y, stim-
ulate a secondary rather than a primary proliferative response [25). 
Based upon studies on human PBM [4,26) one may speculate 
that KC which onl y express HLA-DR antigens are not ca pablc 
of antigen presentation to T helper cells unless they also simul-
taneously express HLA-DQ antigens. In additi on, the presence 
of MAC-1 20, a monocyte antigen which has also been shown to 
acco mpany HLA-DR and HLA-DQ ex pression may be necessa ry 
for effective PBM function [25 ,27) es peciall y in the autologous 
mi xed leukocyte reaction (AMLR). So far KC have not been 
examined for the prescnce of this latter antigen and, consequentl y, 
no definitive conclusions can be drawn as to the role of anti-HLA-
DR + la nti- HLA-DQ + KC ill antigen presentation and , particu-
larl y, in the AMLR. O n thc other hand , HLA-DQ antigens on 
KC may represent targets for certain cy totoxic T lymphocy tes 
(CTL), as has bcen shown fo r CTL clones [28). 
ADDENDUM 
During preparation of this manuscript, comparable findings have 
been described in borrelia-induced sklI1 leSIons (TJernlund U , 
Scheynius A, Asbrink E, Hovmark A: Expression of HLA-DQ 
antigcns on keratin'ocytes in Borrelia spirochete-induced sk in le-
sions . Scand J Immunol 23:383- 388, 1986). 
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